-
NEW YORK – March 30, 2021 – A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for individual pancreatic cancer patients […]
Mar 30,2021
-
Linda Tantawi to Lead National Expansion. WOODBURY, NY – The Lustgarten Foundation today announced the appointment of Linda Tantawi as Chief Executive Officer. As CEO, Tantawi will expand the organization’s […]
Jan 15,2021
-
The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced a remarkable year of funding, awarding 17 new grants to researchers at 13 leading institutions. These […]
Aug 02,2023
-
The PSA aims to raise awareness for pancreatic cancer clinical trials. LOS ANGELES –The Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer® (SU2C), announced […]
Nov 11,2021
-
NEW YORK – The Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer (SU2C), announced today the launch of a new public service announcement (PSA) […]
Nov 11,2021
-
Foundation Attracts New Talent to Study Pancreatic Cancer WOODBURY, NY – The Lustgarten Foundation announced today that it funded $22 million in 2017 as part of its commitment to invest […]
Jan 15,2018
-
By Vanessa Steil- January 21, 2020 January is Pancreatic Cancer Clinical Trials Awareness Month. Clinical trials are important for delivering innovative and potentially life-saving new treatment options to patients. They […]
Jan 21,2020
-
Results from an ongoing phase 2b GRECO-2 clinical trial show that the novel drug GC4419 may be promising in treating patients with unresectable or borderline resectable locally advanced pancreatic cancer […]
Oct 01,2021